Autoimmune rheumatic diseases (ARDs), such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic ...
Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission Positive ENLIGHTEN 2 results highlighted at the ...
North Carolina head coach Bill Belichick spoke to the media at the Kenan Football Center on Tuesday to discuss the upcoming matchup with Clemson, the quarterback controversy and the offensive line.
The AI medical scribe solutions market has boomed in the past year, saving physicians significant time and enhancing the quality of healthcare interactions for patients. They've proven indispensable ...
Talks on resuming International Atomic Energy Agency (IAEA) inspections of Iran’s nuclear sites have made progress, but its chief warned that there was “not much” time remaining. On Monday, the ...
Shares of Protagenic Therapeutics Inc (NASDAQ:PTIX) are trading sharply higher Thursday afternoon, soaring over 100% midday after the company announced a key clinical milestone. What To Know: This ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. I-MAB ( (IMAB)) just unveiled an update.
TARPON SPRINGS, Fla., August 15, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Chronic rare diseases are becoming a major challenge for the aging population in the United States. As life expectancy rises, healthcare needs become more complex, especially for conditions that are ...
In the second quarter, the firm began dosing patients in three signal-seeking clinical trials to evaluate BNT327, its VEGF x PD-L1 bispecific, in combination with antibody-drug conjugates as ...